ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Second time lucky? Alzheon tries for much-reduced IPO
August 29, 2018Alzheon is planning a phase 2b trial. -
Alzheon says data back plans for phase 3 program
July 26, 2018Alzheon is still trying to build a case for a pivotal trial of its Alzheimer’s candidate, and the company says it has new data backing up the drug’s use in patients genetically predisposed to develop the disease. -
Alzheon Launches IPO to Fund Alzheimer's Drug
March 20, 2018Alzheon, based in Framingham, Massachusetts, has filed with the U.S. Securities and Exchange Commission (SEC) to launch an initial public offering (IPO). -
Alzheon to present new clinical data and analyses for ALZ-801
February 16, 2017The presentations highlight Alzheon’s ‘precision medicine’ approach to drug development for Alzheimer’s disease.
Pharma Sources Insight January 2025
